• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back
Cimetidine
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells.
Clinical use: peptic ulcer, gastritis, mild reflux
"Take H2 blockers before you DINE. Think "table for 2" to remember H2."

Toxicity: Cimetidine is a potent inhibitor of P-450; it also
has antiandrogenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross blood-brain barrier (confusion, dizziness, headaches) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.
Ranitidine
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells.
Clinical use: peptic ulcer, gastritis, mild reflux
"Take H2 blockers before you DINE. Think "table for 2" to remember H2."

Toxicity: Cimetidine is a potent inhibitor of P-450; it also
has antiandrogenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross blood-brain barrier (confusion, dizziness, headaches) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.
Famotidine
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells.
Clinical use: peptic ulcer, gastritis, mild reflux
"Take H2 blockers before you DINE. Think "table for 2" to remember H2."

Toxicity: relatively free of toxic effects of cimetidine and ranitidine.
Nizatidine
H2 blocker
Mechanism: Reversible block of histamine H2 receptors --> decreases H+ secretion by parietal cells.
Clinical use: peptic ulcer, gastritis, mild reflux
"Take H2 blockers before you DINE. Think "table for 2" to remember H2."


Toxicity: relatively free of toxic effects of cimetidine and ranitidine.
Omeprazole
PPI
Mechanism: irreversibly inhibits H/K ATPase in stomach parietal cells.
Clinical use: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome.
lansoprazole
PPI
Mechanism: irreversibly inhibits H/K ATPase in stomach parietal cells.
Clinical use: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome.
Bismuth
Sucralfate
Mechanism: bind to the ulcer base, providing physical protection, and allow HCO3- secretion to reestablish pH gradient in the mucous layer.

Clinical use: Increase ulcer healing, traveler's diarrhea
Triple therapy for H. Pylori Ulcers
Metronidazole
Amoxicillin (or Tetracycline)
Bismuth

Can also use PPI
"Please MAke Tummy Better."
Misoprostol
Mechanism: a PGE1 analog. increases the production and secretion of gastric mucous barrier, decreases acid production
Clinical use: prevention of NSAID-induced peptic ulcers; maintenance of patent ductus arteriosus. Also used to induce labor.

Toxicity: Diarrhea. CI in women of childbearing potential (abortifacient)
Pirenzepine
Muscarinic antagonists
Mechanism: Block M1 receptors on ECL cells (decrease histamine secretion) and M3 receptors on
parietal cells (decrease H+secretion).

Clinical use: peptic ulcer (rarely used)

Toxicity: Tachycardia, dry mouth, difficulty focusing eyes.
Propantheline
Muscarinic antagonists
Mechanism: Block M1 receptors on ECL cells (decrease histamine secretion) and M3 receptors on
parietal cells (decrease H+secretion).

Clinical use: peptic ulcer (rarely used)

Toxicity: Tachycardia, dry mouth, difficulty focusing eyes.
Octreotide
Mechanism: SST analog
Clinical use: acute variceal bleeds, acromegaly, VIPoma, carcinoid tumors
Toxicity: nausea, cramps, steatorrhea
Antacid use
Can affect absorption, bioavailability, or urinary excretion of other drugs by altering gastric and urinary pH or by delaying gastric emptying.
Overuse can also cause the following problems:
I. Aluminum hydroxide-constipation and hypophosphatemia; proximal muscle weakness, osteodystrophy, seizures
2. Magnesium hydroxide-diarrhea, hyporeflexia, hypotension, cardiac arrest
3. Calcium carbonate-hypercalcemia,
rebound acid increase.
All can cause hypokalemia.

Can chelate and decrease effectiveness of other drugs, like tetracyclines.
Aluminum hydroxide
constipation and hypophosphatemia; proximal muscle weakness, osteodystrophy, seizures
hypokalemia

"Aluminimum amount of feces"
Magnesium hydroxide
diarrhea, hyporeflexia, hypotension, cardiac arrest
hypokalemia
"Mg = must go to the bathroom"
Calcium Carbonate
hypercalcemia,
rebound acid increase.
hypokalemia
Infliximab
Mechanism: A monoclonal antibody to TNF, proinflammatory cytokine.

Clinical use: Crohn's disease, RA

Toxicity: Respiratory infection (including reactivation of
latent TB), fever, hypotension.

"INFLIXimab INFLIX pain on TNF."
Sulfasalazine
mechanism: A combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory). Reduces synthesis of inflammatory mediators and cytokines in the intestine, it is not absorbed.
Activated by colonic bacteria.

Clinical use: UC and Crohn's disease

Toxicity: malaise, nausea, sulfonamide toxicity, reversible oligospermia
Ondansetron
Mechanism: 5-HT3 antagonist. Powerful central-acting antiemetic.
Clinical use: control vomiting post-operatively and in patients undergoing cancer chemo.
Toxicity: headache, constipation

"You will not vomit with ONDANSetron, so you can go ON DANCing."
Metoclopramide
Mechanism: D2 receptor antagonist. Increases resting tone, contractility, LES tone, motility. Does NOT influence colon transport time.

Clinical use: Diabetic and post-surgery gastroparesis

Toxicity: increased parkinsonian effects (D2 antag). Restlessness, drowsiness, fatigue, depression, nausea, diarrhea.
Drug interaction with digoxin and diabetic agents.
Contraindicated in patients with small bowel obstruction.